# Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE)

> **NCT05335525** · — · UNKNOWN · sponsor: **Terumo Europe N.V.** · enrollment: 230 (estimated)

## Conditions studied

- Vascular Closure
- Endovascular Procedure
- Hemostasis
- Peripheral Vascular Disease
- Femoral Artery

## Interventions

- **DEVICE:** Closure of the femoral arterial puncture site

## Key facts

- **NCT ID:** NCT05335525
- **Lead sponsor:** Terumo Europe N.V.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-30
- **Primary completion:** 2023-05
- **Final completion:** 2023-05
- **Target enrollment:** 230 (ESTIMATED)
- **Last updated:** 2023-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05335525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05335525, "Post-market Clinical Investigation of the Angio-Seal™ VIP VCD (ANGIO-SEAL CLOSE)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05335525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*